Health Care Reveals its Supply Chain Pain
Significant factors contributing to uncertainty in the healthcare supply chain are more stringent regulations and increased product protection challenges
Get Your Head in the Game
Considerations to make when kicking off a track-and-trace program
Physicians Side with Big Pharma in Biosimilar Name Debate
The ongoing debate over whether biosimilars should be given the same INN as brand-name biologics has divided the healthcare industry.
Supply Chain Security Breaches Increase Regulatory Scrutiny, Says Dow Corning
OEMs must comply with additional regulatory requirements